Literature DB >> 26431811

Risk Factors for Decreased Quality of Life in Thyroid Cancer Survivors: Initial Findings from the North American Thyroid Cancer Survivorship Study.

Briseis Aschebrook-Kilfoy1, Benjamin James2, Sapna Nagar3, Sharone Kaplan2, Vanessa Seng2, Habibul Ahsan1, Peter Angelos2, Edwin L Kaplan2, Marlon A Guerrero4, Jennifer H Kuo5, James A Lee5, Elliot J Mitmaker6, Jacob Moalem7, Daniel T Ruan8, Wen T Shen9, Raymon H Grogan2.   

Abstract

BACKGROUND: The prevalence of thyroid cancer survivors is rising rapidly due to the combination of an increasing incidence, high survival rates, and a young age at diagnosis. The physical and psychosocial morbidity of thyroid cancer has not been adequately described, and this study therefore sought to improve the understanding of the impact of thyroid cancer on quality of life (QoL) by conducting a large-scale survivorship study.
METHODS: Thyroid cancer survivors were recruited from a multicenter collaborative network of clinics, national survivorship groups, and social media. Study participants completed a validated QoL assessment tool that measures four morbidity domains: physical, psychological, social, and spiritual effects. Data were also collected on participant demographics, medical comorbidities, tumor characteristics, and treatment modalities.
RESULTS: A total of 1174 participants with thyroid cancer were recruited. Of these, 89.9% were female, with an average age of 48 years, and a mean time from diagnosis of five years. The mean overall QoL was 5.56/10, with 0 being the worst. Scores for each of the sub-domains were 5.83 for physical, 5.03 for psychological, 6.48 for social, and 5.16 for spiritual well-being. QoL scores begin to improve five years after diagnosis. Female sex, young age at diagnosis, and lower educational attainment were highly predictive of decreased QoL.
CONCLUSION: Thyroid cancer diagnosis and treatment can result in a decreased QoL. The present findings indicate that better tools to measure and improve thyroid cancer survivor QoL are needed. The authors plan to follow-up on these findings in the near future, as enrollment and data collection are ongoing.

Entities:  

Mesh:

Year:  2015        PMID: 26431811      PMCID: PMC4684649          DOI: 10.1089/thy.2015.0098

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  24 in total

1.  Cancer-related worry in Canadian thyroid cancer survivors.

Authors:  Lauren Bresner; Rita Banach; Gary Rodin; Lehana Thabane; Shereen Ezzat; Anna M Sawka
Journal:  J Clin Endocrinol Metab       Date:  2014-11-13       Impact factor: 5.958

2.  Health profiles and quality of life of 518 survivors of thyroid cancer.

Authors:  Pamela N Schultz; Charles Stava; Rena Vassilopoulou-Sellin
Journal:  Head Neck       Date:  2003-05       Impact factor: 3.147

3.  Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006.

Authors:  Briseis Aschebrook-Kilfoy; Mary H Ward; Mona M Sabra; Susan S Devesa
Journal:  Thyroid       Date:  2010-12-27       Impact factor: 6.568

Review 4.  Health-related quality of life among thyroid cancer survivors: a systematic review.

Authors:  Olga Husson; Harm R Haak; Wilma A Oranje; Floortje Mols; Peter H M Reemst; Lonneke V van de Poll-Franse
Journal:  Clin Endocrinol (Oxf)       Date:  2011-10       Impact factor: 3.478

5.  Quality of life and barriers to symptom management in colon cancer.

Authors:  Virginia Sun; Tami Borneman; Marianna Koczywas; Mihaela Cristea; Barbara F Piper; Gwen Uman; Betty Ferrell
Journal:  Eur J Oncol Nurs       Date:  2011-07-23       Impact factor: 2.398

6.  Surgeons and patients disagree on the potential consequences from hypoparathyroidism.

Authors:  Nancy L Cho; Jacob Moalem; Lily Chen; Carrie C Lubitz; Francis D Moore; Daniel T Ruan
Journal:  Endocr Pract       Date:  2014-05       Impact factor: 3.443

7.  Unmet information and support needs in newly diagnosed thyroid cancer: comparison of adolescents/young adults (AYA) and older patients.

Authors:  Melanie Goldfarb; Jacqueline Casillas
Journal:  J Cancer Surviv       Date:  2014-02-26       Impact factor: 4.442

8.  International patterns and trends in thyroid cancer incidence, 1973-2002.

Authors:  Briseis A Kilfoy; Tongzhang Zheng; Theodore R Holford; Xuesong Han; Mary H Ward; Andreas Sjodin; Yaqun Zhang; Yana Bai; Cairong Zhu; Grace L Guo; Nathaniel Rothman; Yawei Zhang
Journal:  Cancer Causes Control       Date:  2008-11-19       Impact factor: 2.506

9.  Quality of life with well-differentiated thyroid cancer: treatment toxicities and their reduction.

Authors:  April Mendoza; Brian Shaffer; Daniel Karakla; M Elizabeth Mason; David Elkins; Thomas E Goffman
Journal:  Thyroid       Date:  2004-02       Impact factor: 6.568

10.  Quality of life in patients with thyroid cancer compared with the general population.

Authors:  Susanne Singer; Thomas Lincke; Eva Gamper; Krishnan Bhaskaran; Stefan Schreiber; Andreas Hinz; Thomas Schulte
Journal:  Thyroid       Date:  2011-12-22       Impact factor: 6.568

View more
  30 in total

1.  The Effect of Implementing Gene Expression Classifier on Outcomes of Thyroid Nodules with Indeterminate Cytology.

Authors:  Jithma Prasad Abeykoon; Luke Mueller; Frank Dong; Ashish V Chintakuntlawar; Jonas Paludo; Rami Mortada
Journal:  Horm Cancer       Date:  2016-04-21       Impact factor: 3.869

2.  Papillary Thyroid Cancer: The Good and Bad of the "Good Cancer".

Authors:  Reese W Randle; Norah M Bushman; Jason Orne; Courtney J Balentine; Elizabeth Wendt; Megan Saucke; Susan C Pitt; Cameron L Macdonald; Nadine P Connor; Rebecca S Sippel
Journal:  Thyroid       Date:  2017-06-12       Impact factor: 6.568

3.  Well-differentiated thyroid cancer: Thyroidectomy or lobectomy?

Authors:  Wouter P Kluijfhout; Lorne E Rotstein; Jesse D Pasternak
Journal:  CMAJ       Date:  2016-09-26       Impact factor: 8.262

Review 4.  Total thyroidectomy versus thyroid lobectomy in the treatment of papillary carcinoma.

Authors:  Marco Raffaelli; Serena Elisa Tempera; Luca Sessa; Celestino Pio Lombardi; Carmela De Crea; Rocco Bellantone
Journal:  Gland Surg       Date:  2020-01

5.  Long non-coding RNA H19 knockdown inhibits the cell viability and promotes apoptosis of thyroid cancer cells through regulating the PI3K/AKT pathway.

Authors:  Xiaoyu Li; Qinghuai Li; Xiao Jin; Hao Guo; Yong Li
Journal:  Exp Ther Med       Date:  2019-07-01       Impact factor: 2.447

6.  Post-treatment cognitive dysfunction in women treated with thyroidectomy for papillary thyroid carcinoma.

Authors:  Mi Sook Jung; Moira Visovatti
Journal:  Support Care Cancer       Date:  2016-11-11       Impact factor: 3.603

7.  Patient-Reported Quality-of-Life Outcome Measures in the Thyroid Cancer Population.

Authors:  Eve M Roth; Carrie C Lubitz; John Shannon Swan; Benjamin C James
Journal:  Thyroid       Date:  2020-05-14       Impact factor: 6.568

8.  Measurement and Variation in Estimation of Quality of Life Effects of Patients Undergoing Treatment for Papillary Thyroid Carcinoma.

Authors:  Carrie C Lubitz; Lucia De Gregorio; Abbey L Fingeret; Konstantinos P Economopoulos; Diana Termezawi; Mursal Hassan; Sareh Parangi; Antonia E Stephen; Elkan F Halpern; Karen Donelan; J Shannon Swan
Journal:  Thyroid       Date:  2016-12-15       Impact factor: 6.568

Review 9.  Quality of Life in Thyroid Cancer is Similar to That of Other Cancers with Worse Survival.

Authors:  Megan K Applewhite; Benjamin C James; Sharone P Kaplan; Peter Angelos; Edwin L Kaplan; Raymon H Grogan; Briseis Aschebrook-Kilfoy
Journal:  World J Surg       Date:  2016-03       Impact factor: 3.352

10.  Health-Related Quality of Life and Cosmesis After Thyroidectomy: Long-Term Outcomes.

Authors:  Dimitrios Linos; Spyridon Christodoulou; Vassiliki Kitsou; Angeliki Karachaliou; Spyridon Ntelis; Athanassios Petralias
Journal:  World J Surg       Date:  2020-01       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.